A long-term UK study revealed that in order to prevent poorer health outcomes, changes need to be made to the current way of diagnosing patients with type 2 diabetes…. 

The FDA first rejected the drug combination in February 2011, asking the company to conduct a cardiovascular-outcomes trial because of concerns about the CV safety profile of bupropion/naltrexone when used long-term in a population of overweight and obese subjects…. 

Methazolamide, proven in a study to be beneficial in diabetes treatment, could be the archetype for a new class of agents used to treat type 2 diabetes and related conditions…. 

But results from the longitudinal study also confirmed that improvements in insulin sensitivity were unaltered by weight regain following Roux-en-Y gastric bypass…. 

Sleeve gastrectomy is now a treatment option for patients with obesity to help reduce weight and manage diabetes….

Diabetic women who use sulfonylureas for a long time could have a higher risk of developing CHD…. 

Metformin seems to have positive effects on body composition, insulin sensitivity, and glucose homeostasis in patients recently diagnosed with type 2 diabetes…. 

Slow caffeine metabolizers who drink more than three cups a day have the highest risk…. 

Daughters exposed to maternal hyperglycemia will have a higher risk of childhood adiposity…. 

About one in every 1,000 individuals carries a variant in PPARG, which is treatable with tailored pharmacotherapy….